Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening.

D'haene B, Attanasio C, Beysen D, Dostie J, Lemire E, Bouchard P, Field M, Jones K, Lorenz B, Menten B, Buysse K, Pattyn F, Friedli M, Ucla C, Rossier C, Wyss C, Speleman F, De Paepe A, Dekker J, Antonarakis SE, De Baere E.

PLoS Genet. 2009 Jun;5(6):e1000522. doi: 10.1371/journal.pgen.1000522. Epub 2009 Jun 19.

2.

Foxl2 function in ovarian development.

Uhlenhaut NH, Treier M.

Mol Genet Metab. 2006 Jul;88(3):225-34. Epub 2006 May 2. Review.

PMID:
16647286
3.

FOXL2 impairment in human disease.

Verdin H, De Baere E.

Horm Res Paediatr. 2012;77(1):2-11. doi: 10.1159/000335236. Epub 2012 Jan 12. Review.

4.

FOXL2 mutations and genomic rearrangements in BPES.

Beysen D, De Paepe A, De Baere E.

Hum Mutat. 2009 Feb;30(2):158-69. doi: 10.1002/humu.20807. Review.

PMID:
18726931
5.

Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.

De Baere E, Copelli S, Caburet S, Laissue P, Beysen D, Christin-Maitre S, Bouchard P, Veitia R, Fellous M.

Pediatr Endocrinol Rev. 2005 Jun;2(4):653-60. Review.

PMID:
16208278
6.

The mutations and potential targets of the forkhead transcription factor FOXL2.

Moumné L, Batista F, Benayoun BA, Nallathambi J, Fellous M, Sundaresan P, Veitia RA.

Mol Cell Endocrinol. 2008 Jan 30;282(1-2):2-11. Epub 2007 Nov 19. Review.

PMID:
18155828
7.

The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology.

Caburet S, Georges A, L'Hôte D, Todeschini AL, Benayoun BA, Veitia RA.

Mol Cell Endocrinol. 2012 Jun 5;356(1-2):55-64. doi: 10.1016/j.mce.2011.06.019. Epub 2011 Jul 8. Review.

PMID:
21763750
8.

Supplemental Content

Support Center